Oklahoma professors unveil new approach to cancer therapy

A pair of scientists at the University of Oklahoma say they have developed a fusion protein that can prevent the spread of cancer. The fusion protein blocks cancer cells from ingesting methionine, a protein they need to develop. The researchers have developed a mechanism that delivers the compound directly to cancer cells, avoiding any damage to healthy cells. The research fits into a broad range of programs looking to develop new ways to deliver cancer therapies without harming healthy cells, avoiding harsh side effects linked to chemotherapy. While the professors say they have started with breast cancer research, the same approach should work in a broad array of solid tumor cancers. They expect to conduct another round of animal tests before entering the clinic.

- here's the AP report on the cancer program

Suggested Articles

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.

Selectively targeting TGF-beta1 with Scholar Rock's SRK-181 overcame primary resistance to checkpoint inhibitor therapy in mice.

Enhertu produced a 55.6% objective response rate in HER2-positive non-small cell lung cancer patients in a phase 1 trial.